| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,254,000 | 1,106,000 | 967,000 | 1,208,000 | | Cost of Revenue | 1,043,000 | 913,000 | 827,000 | 1,056,000 | | | Gross Profit | 211,000 | 193,000 | 140,000 | 152,000 | | | Operating Expenses | | Research Development | 27,000 | 24,000 | 21,000 | 28,000 | | Selling General and Administrative | 90,000 | 88,000 | 78,000 | 98,000 | | Non Recurring |
-
|
-
|
-
| 114,000 | | Others | 55,000 | 55,000 | 52,000 | 54,000 | | | | Total Operating Expenses |
-
|
-
|
-
| 294,000 | | | | Operating Income or Loss | 39,000 | 26,000 | (11,000) | (142,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,000) | (7,000) | (2,000) | (3,000) | | Earnings Before Interest And Taxes | (33,000) | 88,000 | (16,000) | (120,000) | | Interest Expense | (68,000) | 37,000 | 31,000 | 25,000 | | Income Before Tax | 35,000 | 51,000 | (47,000) | (145,000) | | Income Tax Expense | 4,000 | 11,000 | 3,000 | 126,000 | | Minority Interest | (4,000) | (6,000) |
-
| (2,000) | | | | Net Income From Continuing Ops | 93,000 | (35,000) | (47,000) | (298,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,000) | (35,000) | (47,000) | (298,000) | | Preferred Stock And Other Adjustments |
-
| 2,000 | (2,000) |
-
| | | Net Income Applicable To Common Shares | ($8,000) | ($33,000) | ($49,000) | ($298,000) |
|
0.02% Nasdaq 0.00%
Income Statement
